| Dr Austin Michael Beason, MD | |
|
701 N 1st St, Springfield, IL 62702-3757 | |
| (217) 545-8000 | |
| Not Available |
| Full Name | Dr Austin Michael Beason |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 701 N 1st St, Springfield, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114418951 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 125071948 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Austin Michael Beason, MD Po Box 19638, Springfield, IL 62794-9638 Ph: (217) 545-8000 | Dr Austin Michael Beason, MD 701 N 1st St, Springfield, IL 62702-3757 Ph: (217) 545-8000 |
News Archive
In 2012 researchers from the German Institute for Quality and Efficiency in Health Care (IQWiG) presented a study in the BMJ analysing information sources used in 16 health technology assessment (HTA) reports of drugs ("benefit assessments").
Health officials from the Maryland Department of Health and Mental Hygiene and the Baltimore Health Department plan to hold the first in a series of meetings this month to discuss the links between commercial sex work and HIV transmission in an effort to curb the spread of the disease in the Baltimore area, the Baltimore Sun reports (Bor, Baltimore Sun, 11/9).
To lose weight, boost energy or soothe nerves, many consumers turn to dietary supplements. But some of these products contain undeclared substances. To protect consumers from taking something without their knowledge, scientists have developed a technique to determine what secret ingredients could be lurking in these supplements.
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
› Verified 7 days ago
Elliot M Johns, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 301 N 8th St Ste 3a158, Springfield, IL 62701 Phone: 317-697-6136 | |
Kathleen Kay, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 701 N 1st St, Springfield, IL 62702 Phone: 217-545-8000 Fax: 217-545-1159 | |
John R Fisk, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 N 8th St, Springfield, IL 62701 Phone: 217-545-7500 Fax: 217-545-7305 | |
Dr. Piero Capecci, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 N 1st St, Springfield, IL 62702 Phone: 217-528-7541 | |
Jasmin L Mcginty, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 N 8th St, Ste Pav3b, Springfield, IL 62701 Phone: 217-545-7500 Fax: 217-545-7305 | |
Christopher Evan Bejcek, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 701 N 1st St, Springfield, IL 62702 Phone: 217-545-8000 Fax: 217-545-1159 |